Breaking News Instant updates and real-time market news.

COVTY

Covestro

$0.00 /

+ (+0.00%)

14:40
02/25/21
02/25
14:40
02/25/21
14:40

Covestro price target raised to EUR 65 from EUR 60 at Berenberg

Berenberg analyst Sebastian Bray raised the firm's price target on Covestro to EUR 65 from EUR 60 and keeps a Hold rating on the shares.

COVTY Covestro
$0.00 /

+ (+0.00%)

02/25/21 Societe Generale
Covestro price target raised to EUR 74 from EUR 65 at Societe Generale
02/24/21 Barclays
Covestro price target raised to EUR 68 from EUR 64 at Barclays
02/24/21 Credit Suisse
Covestro price target raised to EUR 65 from EUR 54 at Credit Suisse
02/24/21 Deutsche Bank
Covestro price target raised to EUR 76 from EUR 65 at Deutsche Bank

TODAY'S FREE FLY STORIES

Hot Stocks
Delta Air Lines seeing more normal booking behavior for spring, summer travel » 10:06
04/15/21
04/15
10:06
04/15/21
10:06
DAL

Delta Air Lines

$46.93 /

-1.22 (-2.53%)

CEO Ed Bastian says…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DAL Delta Air Lines
$46.93 /

-1.22 (-2.53%)

DAL Delta Air Lines
$46.93 /

-1.22 (-2.53%)

06:55 Today Barclays
Delta Air Lines price target raised to $52 from $42 at Barclays
04/14/21 JPMorgan
Delta Air Lines price target raised to $63 from $49 at JPMorgan
04/09/21 Cowen
Delta Air Lines price target raised to $53 from $44 at Cowen
04/06/21 Morgan Stanley
Delta Air Lines price target raised to $72 from $55 at Morgan Stanley
DAL Delta Air Lines
$46.93 /

-1.22 (-2.53%)

DAL Delta Air Lines
$46.93 /

-1.22 (-2.53%)

DAL Delta Air Lines
$46.93 /

-1.22 (-2.53%)

DAL Delta Air Lines
$46.93 /

-1.22 (-2.53%)

Options
Visa call volume above normal and directionally bullish » 10:05
04/15/21
04/15
10:05
04/15/21
10:05
V

Visa

$227.05 /

+4.91 (+2.21%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
V Visa
$227.05 /

+4.91 (+2.21%)

V Visa
$227.05 /

+4.91 (+2.21%)

03/19/21 JPMorgan
Visa has 'navigated heavy regulatory oversight' before, says JPMorgan
03/19/21 Wells Fargo
Visa selloff on WSJ story likely a buying opportunity, says Wells Fargo
03/19/21 Barclays
Visa, MasterCard facing new DOJ scrutiny on debt practices, says Barclays
03/16/21 Morgan Stanley
Visa price target raised to $253 from $233 at Morgan Stanley
V Visa
$227.05 /

+4.91 (+2.21%)

  • 13
    Oct
V Visa
$227.05 /

+4.91 (+2.21%)

V Visa
$227.05 /

+4.91 (+2.21%)

V Visa
$227.05 /

+4.91 (+2.21%)

Recommendations
Apria price target raised to $33 from $29 at Piper Sandler » 10:04
04/15/21
04/15
10:04
04/15/21
10:04
APR

Apria

$29.21 /

-0.77 (-2.57%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APR Apria
$29.21 /

-0.77 (-2.57%)

APR Apria
$29.21 /

-0.77 (-2.57%)

03/31/21 Citi
Apria price target raised to $30 from $26 at Citi
03/31/21 Piper Sandler
Apria price target raised to $29 from $27 at Piper Sandler
03/24/21 Citi
CMS oxygen rate change may drive upside for Apria, says Citi
03/08/21 Citi
Apria initiated with a Buy at Citi
APR Apria
$29.21 /

-0.77 (-2.57%)

  • 11
    Feb
APR Apria
$29.21 /

-0.77 (-2.57%)

Initiation
Immunic initiated with a Buy at Aegis » 10:03
04/15/21
04/15
10:03
04/15/21
10:03
IMUX

Immunic

$14.50 /

+ (+0.00%)

Aegis analyst Nathan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IMUX Immunic
$14.50 /

+ (+0.00%)

IMUX Immunic
$14.50 /

+ (+0.00%)

03/24/21
Fly Intel: Top five analyst initiations
03/24/21 JMP Securities
Immunic initiated with an Outperform at JMP Securities
02/26/21 Roth Capital
Immunic shares a 'bargain' ahead of 'derisking catalysts,' says Roth Capital
02/26/21 Piper Sandler
Piper remains 'bullish' on Immunic progress with IMU-838 after Q4 update
IMUX Immunic
$14.50 /

+ (+0.00%)

  • 05
    Aug
  • 10
    Jun
IMUX Immunic
$14.50 /

+ (+0.00%)

Hot Stocks
Citi 'optimistic' about recovery ahead » 10:02
04/15/21
04/15
10:02
04/15/21
10:02
C

Citi

$73.64 /

+0.72 (+0.99%)

Comments taken from Q1…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
C Citi
$73.64 /

+0.72 (+0.99%)

C Citi
$73.64 /

+0.72 (+0.99%)

04/13/21 Morgan Stanley
Citi price target raised to $89 from $81 at Morgan Stanley
04/09/21 Jefferies
Citi price target raised to $85 from $75 at Jefferies
04/07/21 Barclays
Citi price target raised to $84 from $77 at Barclays
04/05/21 Cowen
Risk to mortgage servicers rises as CFPB proposes foreclosure policy, says Cowen
C Citi
$73.64 /

+0.72 (+0.99%)

C Citi
$73.64 /

+0.72 (+0.99%)

C Citi
$73.64 /

+0.72 (+0.99%)

C Citi
$73.64 /

+0.72 (+0.99%)

General news
February business inventories up 0.5% vs. last month, consensus 0.5%  10:02
04/15/21
04/15
10:02
04/15/21
10:02
$ECON

Economic Data

/

+

 
ShowHide Related Items >><<
    General news
    April housing market index 83, consensus 83  10:02
    04/15/21
    04/15
    10:02
    04/15/21
    10:02
    $ECON

    Economic Data

    /

    +

     
    ShowHide Related Items >><<
      Hot Stocks
      Veeva, Parexel to accelerate clinical trials » 10:01
      04/15/21
      04/15
      10:01
      04/15/21
      10:01
      VEEV

      Veeva

      $274.29 /

      +6.11 (+2.28%)

      Parexel and Veeva Systems…

      Story temporarily locked.
      To read stories as they happen please subscribe, Login above, or return tomorrow

      Get Free Trial

      ShowHide Related Items >><<
      VEEV Veeva
      $274.29 /

      +6.11 (+2.28%)

      VEEV Veeva
      $274.29 /

      +6.11 (+2.28%)

      04/13/21 Piper Sandler
      Veeva should be bought on 'underappreciated' growth drivers, says Piper Sandler
      03/31/21
      Fly Intel: Top five analyst upgrades
      03/31/21 UBS
      Veeva upgraded to Neutral from Sell at UBS
      03/31/21 UBS
      Veeva upgraded to Neutral from Sell at UBS
      VEEV Veeva
      $274.29 /

      +6.11 (+2.28%)

      VEEV Veeva
      $274.29 /

      +6.11 (+2.28%)

      Hot Stocks
      Virgin Galactic falls -8.1% » 10:00
      04/15/21
      04/15
      10:00
      04/15/21
      10:00
      SPCE

      Virgin Galactic

      $24.47 /

      -2.18 (-8.18%)

      Virgin Galactic is down…

      Story temporarily locked.
      To read stories as they happen please subscribe, Login above, or return in 9 minutes

      Get Free Trial

      ShowHide Related Items >><<
      SPCE Virgin Galactic
      $24.47 /

      -2.18 (-8.18%)

      SPCE Virgin Galactic
      $24.47 /

      -2.18 (-8.18%)

      04/12/21 Bernstein
      Virgin Galactic initiated with a Market Perform at Bernstein
      03/16/21 Truist
      Truist starts 'uniquely positioned' Virgin Galactic at Buy with $50 price target
      03/16/21 Truist
      Virgin Galactic initiated with a Buy at Truist
      03/03/21 BofA
      Virgin Galactic price target raised to $50 from $35 at BofA
      SPCE Virgin Galactic
      $24.47 /

      -2.18 (-8.18%)

      • 06
        Aug
      • 03
        Jun
      • 20
        May
      SPCE Virgin Galactic
      $24.47 /

      -2.18 (-8.18%)

      SPCE Virgin Galactic
      $24.47 /

      -2.18 (-8.18%)

      SPCE Virgin Galactic
      $24.47 /

      -2.18 (-8.18%)

      Hot Stocks
      Orchid Island Capital falls -8.6% » 10:00
      04/15/21
      04/15
      10:00
      04/15/21
      10:00
      ORC

      Orchid Island Capital

      $5.61 /

      -0.53 (-8.63%)

      Orchid Island Capital is…

      Story temporarily locked.
      To read stories as they happen please subscribe, Login above, or return tomorrow

      Get Free Trial

      ShowHide Related Items >><<
      ORC Orchid Island Capital
      $5.61 /

      -0.53 (-8.63%)

      09:43 Today JonesTrading
      Orchid Island Capital downgraded to Sell from Hold at JonesTrading
      10/30/20 Ladenburg
      Orchid Island Capital upgraded to Buy from Neutral at Ladenburg
      ORC Orchid Island Capital
      $5.61 /

      -0.53 (-8.63%)

      • 03
        Mar
      • 21
        Jan
      ORC Orchid Island Capital
      $5.61 /

      -0.53 (-8.63%)

      Hot Stocks
      Natuzzi falls -9.6% » 10:00
      04/15/21
      04/15
      10:00
      04/15/21
      10:00
      NTZ

      Natuzzi

      $13.75 /

      -0.95 (-6.46%)

      Natuzzi is down -9.6%, or…

      Story temporarily locked.
      To read stories as they happen please subscribe, Login above, or return in 9 minutes

      Get Free Trial

      ShowHide Related Items >><<
      NTZ Natuzzi
      $13.75 /

      -0.95 (-6.46%)

      Hot Stocks
      AMC Entertainment rises 7.2% » 10:00
      04/15/21
      04/15
      10:00
      04/15/21
      10:00
      AMC

      AMC Entertainment

      $10.07 /

      +0.725 (+7.76%)

      AMC Entertainment is up…

      Story temporarily locked.
      To read stories as they happen please subscribe, Login above, or return tomorrow

      Get Free Trial

      ShowHide Related Items >><<
      AMC AMC Entertainment
      $10.07 /

      +0.725 (+7.76%)

      AMC AMC Entertainment
      $10.07 /

      +0.725 (+7.76%)

      04/05/21 B. Riley Securities
      B. Riley upgrades AMC to Buy with $13 target after 'impressive' weekend
      04/05/21 B. Riley Securities
      AMC Entertainment upgraded to Buy from Neutral at B. Riley Securities
      03/16/21 Citi
      Citi keeps $2 target on AMC Entertainment, says shares overvalued
      03/11/21 B. Riley Securities
      AMC Entertainment price target raised to $7 from $5.50 at B. Riley Securities
      AMC AMC Entertainment
      $10.07 /

      +0.725 (+7.76%)

      AMC AMC Entertainment
      $10.07 /

      +0.725 (+7.76%)

      AMC AMC Entertainment
      $10.07 /

      +0.725 (+7.76%)

      AMC AMC Entertainment
      $10.07 /

      +0.725 (+7.76%)

      Hot Stocks
      Linx S.A. rises 7.7% » 10:00
      04/15/21
      04/15
      10:00
      04/15/21
      10:00
      LINX

      Linx S.A.

      $6.74 /

      +0.1 (+1.51%)

      Linx S.A. is up 7.7%, or…

      Story temporarily locked.
      To read stories as they happen please subscribe, Login above, or return in 9 minutes

      Get Free Trial

      ShowHide Related Items >><<
      LINX Linx S.A.
      $6.74 /

      +0.1 (+1.51%)

      LINX Linx S.A.
      $6.74 /

      +0.1 (+1.51%)

      12/23/20 Santander
      Linx S.A. initiated with a Hold at Santander
      08/20/20 HSBC
      Linx S.A. downgraded to Reduce from Hold at HSBC
      08/14/20 Jefferies
      Competing bid raises odds of higher price for Linx, says Jefferies
      08/12/20 Jefferies
      Linx S.A. downgraded to Hold from Buy at Jefferies
      Hot Stocks
      Weingarten Realty rises 9.9% » 10:00
      04/15/21
      04/15
      10:00
      04/15/21
      10:00
      WRI

      Weingarten Realty

      $30.09 /

      +2.715 (+9.92%)

      Weingarten Realty is up…

      Story temporarily locked.
      To read stories as they happen please subscribe, Login above, or return tomorrow

      Get Free Trial

      ShowHide Related Items >><<
      WRI Weingarten Realty
      $30.09 /

      +2.715 (+9.92%)

      WRI Weingarten Realty
      $30.09 /

      +2.715 (+9.92%)

      04/13/21 Baird
      Weingarten Realty reinstated with an Outperform at Baird
      03/09/21 BTIG
      Weingarten Realty price target raised to $28 from $25 at BTIG
      03/05/21 Truist
      Weingarten Realty price target raised to $28 from $24 at Truist
      01/28/21 Scotiabank
      Weingarten Realty upgraded to Outperform at Scotiabank on 'Sunbelt preference'
      WRI Weingarten Realty
      $30.09 /

      +2.715 (+9.92%)

      Hot Stocks
      Bank of America sees Q2 expenses 'just north' of $14B » 09:59
      04/15/21
      04/15
      09:59
      04/15/21
      09:59
      BAC

      Bank of America

      $38.77 /

      -1.13 (-2.83%)

      Expects expenses to rise…

      Story temporarily locked.
      To read stories as they happen please subscribe, Login above, or return in 9 minutes

      Get Free Trial

      ShowHide Related Items >><<
      BAC Bank of America
      $38.77 /

      -1.13 (-2.83%)

      BAC Bank of America
      $38.77 /

      -1.13 (-2.83%)

      04/09/21 Jefferies
      Bank of America price target raised to $41 from $33 at Jefferies
      04/07/21 Barclays
      Bank of America price target raised to $45 from $40 at Barclays
      04/05/21 Cowen
      Risk to mortgage servicers rises as CFPB proposes foreclosure policy, says Cowen
      04/01/21 Deutsche Bank
      Bank of America price target raised to $44 from $35 at Deutsche Bank
      BAC Bank of America
      $38.77 /

      -1.13 (-2.83%)

      BAC Bank of America
      $38.77 /

      -1.13 (-2.83%)

      BAC Bank of America
      $38.77 /

      -1.13 (-2.83%)

      BAC Bank of America
      $38.77 /

      -1.13 (-2.83%)

      Hot Stocks
      Reuters to put website behind paywall, charge $34.99 per month » 09:55
      04/15/21
      04/15
      09:55
      04/15/21
      09:55
      TRI

      Thomson Reuters

      $92.12 /

      +1.08 (+1.19%)

      Reuters announced a new…

      Story temporarily locked.
      To read stories as they happen please subscribe, Login above, or return tomorrow

      Get Free Trial

      ShowHide Related Items >><<
      TRI Thomson Reuters
      $92.12 /

      +1.08 (+1.19%)

      TRI Thomson Reuters
      $92.12 /

      +1.08 (+1.19%)

      02/24/21 National Bank
      Thomson Reuters price target raised to C$122 from C$115 at National Bank
      02/24/21 TD Securities
      Thomson Reuters price target raised to C$125 from C$120 at TD Securities
      02/24/21
      Fly Intel: Top five analyst upgrades
      02/24/21 BMO Capital
      Thomson Reuters price target raised to $127 from $116 at BMO Capital
      TRI Thomson Reuters
      $92.12 /

      +1.08 (+1.19%)

      Options
      Early notable gainers among liquid option names on April 15th » 09:55
      04/15/21
      04/15
      09:55
      04/15/21
      09:55
      NVDA

      Nvidia

      $638.50 /

      +27.95 (+4.58%)

      , UNH

      UnitedHealth

      $388.16 /

      +12.41 (+3.30%)

      , PGR

      Progressive

      $99.39 /

      +2.17 (+2.23%)

      , REGN

      Regeneron

      $493.50 /

      +12.82 (+2.67%)

      , PYPL

      PayPal

      $274.92 /

      +7.48 (+2.80%)

      Notable gainers among…

      Story temporarily locked.
      To read stories as they happen please subscribe, Login above, or return in 9 minutes

      Get Free Trial

      ShowHide Related Items >><<
      NVDA Nvidia
      $638.50 /

      +27.95 (+4.58%)

      UNH UnitedHealth
      $388.16 /

      +12.41 (+3.30%)

      PGR Progressive
      $99.39 /

      +2.17 (+2.23%)

      REGN Regeneron
      $493.50 /

      +12.82 (+2.67%)

      PYPL PayPal
      $274.92 /

      +7.48 (+2.80%)

      NVDA Nvidia
      $638.50 /

      +27.95 (+4.58%)

      07:25 Today Raymond James
      Nvidia upgraded to Strong Buy from Outperform at Raymond James
      07:00 Today Raymond James
      Nvidia upgraded to Strong Buy from Outperform at Raymond James
      04/14/21 Jefferies
      Jefferies says Nvidia DC CPU launch, partnerships support earnings power thesis
      04/13/21 Wells Fargo
      Nvidia price target raised to $715 from $625 at Wells Fargo
      UNH UnitedHealth
      $388.16 /

      +12.41 (+3.30%)

      04/14/21 Truist
      UnitedHealth price target raised to $450 from $420 at Truist
      04/09/21 Mizuho
      UnitedHealth price target raised to $394 from $380 at Mizuho
      03/17/21 Stephens
      Amazon news latest sign of rising telehealth competition, says Stephens
      01/28/21 Stephens
      Anthem price target lowered to $340 from $350 at Stephens
      PGR Progressive
      $99.39 /

      +2.17 (+2.23%)

      03/18/21 Edward Jones
      Progressive upgraded to Buy from Hold at Edward Jones
      03/09/21 BofA
      BofA starts Root at Underperform with $9 price target
      02/01/21 Deutsche Bank
      Progressive price target lowered to $105 from $108 at Deutsche Bank
      01/13/21 Gordon Haskett
      Allstate lowering auto rates by 5% in several states, says Gordon Haskett
      REGN Regeneron
      $493.50 /

      +12.82 (+2.67%)

      04/12/21 Benchmark
      Benchmark sees full FDA approval of Regeneron's REGEN-COV coming
      03/24/21 Canaccord
      Regeneron trial shows positive results against COVID-variants, says Canaccord
      03/23/21 Piper Sandler
      Regeneron lower dose cocktail likely to be added to EUA, says Piper Sandler
      03/11/21 Evercore ISI
      Kodiak Sciences initiated with an Outperform at Evercore ISI
      PYPL PayPal
      $274.92 /

      +7.48 (+2.80%)

      04/07/21
      Fly Intel: Top five analyst initiations
      04/07/21 Oddo BHF
      PayPal initiated with an Outperform at Oddo BHF
      03/19/21 Susquehanna
      PayPal chances of crypto success likely, says Susquehanna
      03/12/21
      Fly Intel: Top five analyst initiations
      NVDA Nvidia
      $638.50 /

      +27.95 (+4.58%)

      UNH UnitedHealth
      $388.16 /

      +12.41 (+3.30%)

      PGR Progressive
      $99.39 /

      +2.17 (+2.23%)

      REGN Regeneron
      $493.50 /

      +12.82 (+2.67%)

      PYPL PayPal
      $274.92 /

      +7.48 (+2.80%)

      • 27
        May
      NVDA Nvidia
      $638.50 /

      +27.95 (+4.58%)

      UNH UnitedHealth
      $388.16 /

      +12.41 (+3.30%)

      REGN Regeneron
      $493.50 /

      +12.82 (+2.67%)

      PYPL PayPal
      $274.92 /

      +7.48 (+2.80%)

      NVDA Nvidia
      $638.50 /

      +27.95 (+4.58%)

      UNH UnitedHealth
      $388.16 /

      +12.41 (+3.30%)

      REGN Regeneron
      $493.50 /

      +12.82 (+2.67%)

      PYPL PayPal
      $274.92 /

      +7.48 (+2.80%)

      NVDA Nvidia
      $638.50 /

      +27.95 (+4.58%)

      UNH UnitedHealth
      $388.16 /

      +12.41 (+3.30%)

      PGR Progressive
      $99.39 /

      +2.17 (+2.23%)

      REGN Regeneron
      $493.50 /

      +12.82 (+2.67%)

      PYPL PayPal
      $274.92 /

      +7.48 (+2.80%)

      Conference/Events
      FDA Cellular, Tissue & Gene Therapies Advisory Committee Meeting » 09:55
      04/15/21
      04/15
      09:55
      04/15/21
      09:55

      The Committee discusses…

      Story temporarily locked.
      To read stories as they happen please subscribe, Login above, or return tomorrow

      Get Free Trial

      Conference/Events
      Franco-Nevada to host virtual analyst day » 09:55
      04/15/21
      04/15
      09:55
      04/15/21
      09:55
      FNV

      Franco-Nevada

      $135.49 /

      +2.55 (+1.92%)

      Virtual analyst day to be…

      Story temporarily locked.
      To read stories as they happen please subscribe, Login above, or return in 9 minutes

      Get Free Trial

      ShowHide Related Items >><<
      FNV Franco-Nevada
      $135.49 /

      +2.55 (+1.92%)

      FNV Franco-Nevada
      $135.49 /

      +2.55 (+1.92%)

      03/12/21 National Bank
      Franco-Nevada price target lowered to C$205 from C$210 at National Bank
      03/12/21 Barclays
      Franco-Nevada upgraded to Equal Weight from Underweight at Barclays
      03/07/21 BMO Capital
      Franco-Nevada upgraded to Outperform from Market Perform at BMO Capital
      03/04/21 JPMorgan
      Franco-Nevada initiated with a Neutral at JPMorgan
      FNV Franco-Nevada
      $135.49 /

      +2.55 (+1.92%)

      FNV Franco-Nevada
      $135.49 /

      +2.55 (+1.92%)

      FNV Franco-Nevada
      $135.49 /

      +2.55 (+1.92%)

      Hot Stocks
      GlaxoSmithKline, Vir Biotechnology announce EMA review of VIR-7831 » 09:54
      04/15/21
      04/15
      09:54
      04/15/21
      09:54
      GSK

      GlaxoSmithKline

      $38.02 /

      +1.895 (+5.25%)

      , VIR

      Vir Biotechnology

      $45.02 /

      -0.36 (-0.79%)

      GlaxoSmithKline (GSK) and…

      Story temporarily locked.
      To read stories as they happen please subscribe, Login above, or return tomorrow

      Get Free Trial

      ShowHide Related Items >><<
      GSK GlaxoSmithKline
      $38.02 /

      +1.895 (+5.25%)

      VIR Vir Biotechnology
      $45.02 /

      -0.36 (-0.79%)

      GSK GlaxoSmithKline
      $38.02 /

      +1.895 (+5.25%)

      03/23/21
      Fly Intel: Top five analyst downgrades
      03/23/21 SVB Leerink
      SVB Leerink moving to sidelines on Alexion, five others on industry concerns
      03/23/21 SVB Leerink
      GlaxoSmithKline downgraded to Market Perform from Outperform at SVB Leerink
      03/08/21 JPMorgan
      JPMorgan double downgrades AnaptysBio back to Underweight after trial miss
      VIR Vir Biotechnology
      $45.02 /

      -0.36 (-0.79%)

      03/11/21 Needham
      Vir Biotechnology price target raised to $80 from $75 at Needham
      03/08/21 H.C. Wainwright
      Vir Biotechnology price target raised to $135 from $125 at H.C. Wainwright
      03/03/21 Goldman Sachs
      Vir Biotechnology price target lowered to $59 from $61 at Goldman Sachs
      03/03/21 H.C. Wainwright
      Vir Biotechnology selloff a 'terrific buying opportunity,' says H.C. Wainwright
      GSK GlaxoSmithKline
      $38.02 /

      +1.895 (+5.25%)

      VIR Vir Biotechnology
      $45.02 /

      -0.36 (-0.79%)

      • 08
        Jul
      GSK GlaxoSmithKline
      $38.02 /

      +1.895 (+5.25%)

      GSK GlaxoSmithKline
      $38.02 /

      +1.895 (+5.25%)

      VIR Vir Biotechnology
      $45.02 /

      -0.36 (-0.79%)

      GSK GlaxoSmithKline
      $38.02 /

      +1.895 (+5.25%)

      Initiation
      Fly Intel: Top five analyst initiations » 09:53
      04/15/21
      04/15
      09:53
      04/15/21
      09:53
      COIN

      Coinbase

      $335.00 /

      +6.95 (+2.12%)

      , AMD

      AMD

      $80.95 /

      +2.41 (+3.07%)

      , CRWD

      Crowdstrike

      $213.41 /

      +5.19 (+2.49%)

      , XGN

      Exagen

      $17.42 /

      +0.55 (+3.26%)

      , VC

      Visteon

      $119.19 /

      +0.07 (+0.06%)

      Catch up on today's…

      Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Coinbase (COIN) initiated with a Buy at BTIG. 2. AMD (AMD) initiated with an Outperform at Raymond James. 3. Crowdstrike (CRWD) initiated with a Buy at Deutsche Bank. 4. Exagen (XGN) initiated with a Buy at Canaccord. 5. Visteon (VC) initiated with a Sector Weight at KeyBanc. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

      ShowHide Related Items >><<
      COIN Coinbase
      $335.00 /

      +6.95 (+2.12%)

      AMD AMD
      $80.95 /

      +2.41 (+3.07%)

      CRWD Crowdstrike
      $213.41 /

      +5.19 (+2.49%)

      XGN Exagen
      $17.42 /

      +0.55 (+3.26%)

      VC Visteon
      $119.19 /

      +0.07 (+0.06%)

      COIN Coinbase
      $335.00 /

      +6.95 (+2.12%)

      08:25 Today DA Davidson
      Coinbase price target raised to $650 from $440 at DA Davidson
      05:33 Today BTIG
      Coinbase initiated with a Buy at BTIG
      04/13/21
      Fly Intel: Top five analyst initiations
      04/13/21 MoffettNathanson
      Coinbase initiated with a Buy at MoffettNathanson
      AMD AMD
      $80.95 /

      +2.41 (+3.07%)

      07:21 Today Raymond James
      AMD initiated with an Outperform at Raymond James
      06:58 Today Raymond James
      AMD initiated with an Outperform at Raymond James
      04/12/21 Lynx
      Intel, AMD selloffs on Nvidia 'Grace' news a buying opportunity, says Lynx
      04/06/21 Raymond James
      Performance gap between Intel, AMD 'remains massive,' says Raymond James
      CRWD Crowdstrike
      $213.41 /

      +5.19 (+2.49%)

      06:22 Today Deutsche Bank
      Deutsche starts Crowdstrike with Buy rating, $265 price target
      06:18 Today Deutsche Bank
      Crowdstrike initiated with a Buy at Deutsche Bank
      04/09/21 JPMorgan
      Crowdstrike price target raised to $210 from $205 at JPMorgan
      04/09/21 JMP Securities
      Crowdstrike price target lowered to $265 from $295 at JMP Securities
      XGN Exagen
      $17.42 /

      +0.55 (+3.26%)

      07:32 Today Canaccord
      Canaccord starts Exagen at Buy, sees 50% upside potential
      06:05 Today Canaccord
      Exagen initiated with a Buy at Canaccord
      03/17/21 Cowen
      Exagen price target raised to $26 from $21 at Cowen
      12/29/20 Cantor Fitzgerald
      Exagen amended Janssen terms removes uncertainty, says Cantor Fitzgerald
      VC Visteon
      $119.19 /

      +0.07 (+0.06%)

      08:51 Today Barclays
      Barclays shuffles ratings in Auto Parts into 'summer recovery'
      08:28 Today Barclays
      Visteon downgraded to Equal Weight from Overweight at Barclays
      08:11 Today KeyBanc
      Visteon initiated with a Sector Weight at KeyBanc on chip shortage exposure
      04/14/21 KeyBanc
      Visteon initiated with a Sector Weight at KeyBanc
      COIN Coinbase
      $335.00 /

      +6.95 (+2.12%)

      AMD AMD
      $80.95 /

      +2.41 (+3.07%)

      CRWD Crowdstrike
      $213.41 /

      +5.19 (+2.49%)

      XGN Exagen
      $17.42 /

      +0.55 (+3.26%)

      VC Visteon
      $119.19 /

      +0.07 (+0.06%)

      • 14
        Apr
      • 23
        Mar
      • 26
        Jun
      COIN Coinbase
      $335.00 /

      +6.95 (+2.12%)

      AMD AMD
      $80.95 /

      +2.41 (+3.07%)

      CRWD Crowdstrike
      $213.41 /

      +5.19 (+2.49%)

      COIN Coinbase
      $335.00 /

      +6.95 (+2.12%)

      AMD AMD
      $80.95 /

      +2.41 (+3.07%)

      CRWD Crowdstrike
      $213.41 /

      +5.19 (+2.49%)

      XGN Exagen
      $17.42 /

      +0.55 (+3.26%)

      AMD AMD
      $80.95 /

      +2.41 (+3.07%)

      CRWD Crowdstrike
      $213.41 /

      +5.19 (+2.49%)

      Downgrade
      Fly Intel: Top five analyst downgrades » 09:53
      04/15/21
      04/15
      09:53
      04/15/21
      09:53
      INTC

      Intel

      $64.14 /

      -0.08 (-0.12%)

      , VMW

      VMware

      $154.50 /

      -0.99 (-0.64%)

      , KSU

      Kansas City Southern

      $262.01 /

      +1.15 (+0.44%)

      , CAPL

      CrossAmerica

      $19.49 /

      +0.04 (+0.21%)

      , PXD

      Pioneer Natural

      $150.74 /

      -2.39 (-1.56%)

      Catch up on today's…

      Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Intel (INTC) downgraded to Underperform from Market Perform at Raymond James with analyst Chris Caso saying the risk that Intel won't reach its goals under new leadership, and also the pain they will likely endure in pursuit of that goal in terms of capex, lost market share, and a shifting landscape in datacenter that will make the industry less dependent on Intel. 2. VMware (VMW) downgraded to Market Perform from Outperform at Northland with analyst Nehal Chokshi saying the spinoff from Dell Technologies (DELL) should result in an governance structure theoretically and improved partner ecosystem, but this his unlikely on a practical basis, noting the spin proposal reduces VMware's financial flexibility and introduces incremental risks to business. 3. Kansas City Southern (KSU) downgraded to Equal Weight from Overweight at Wells Fargo with analyst Allison Poliniak-Cusic viewing the probability of the merger proceeding as greater than 50%, and believes another potential bidder is unlikely to step in. 4. CrossAmerica (CAPL) downgraded to Market Perform from Outperform at Raymond James with analyst Justin Jenkins citing valuation and a more balanced risk/reward. 5. Pioneer Natural (PXD) downgraded to Sector Perform from Outperform at Scotiabank with analyst Paul Cheng saying management is repositioning the company to "the right business model," but the shares appear to have largely reflected these favorable developments. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

      ShowHide Related Items >><<
      INTC Intel
      $64.14 /

      -0.08 (-0.12%)

      VMW VMware
      $154.50 /

      -0.99 (-0.64%)

      KSU Kansas City Southern
      $262.01 /

      +1.15 (+0.44%)

      PXD Pioneer Natural
      $150.74 /

      -2.39 (-1.56%)

      INTC Intel
      $64.14 /

      -0.08 (-0.12%)

      09:47 Today Argus
      Lam Research price target raised to $725 from $625 at Argus
      07:23 Today Raymond James
      Intel downgraded to Underperform from Market Perform at Raymond James
      07:21 Today Raymond James
      AMD initiated with an Outperform at Raymond James
      07:00 Today Raymond James
      Intel downgraded to Underperform from Market Perform at Raymond James
      VMW VMware
      $154.50 /

      -0.99 (-0.64%)

      08:45 Today Evercore ISI
      Dell Technologies price target raised to $110 from $105 at Evercore ISI
      08:37 Today Wells Fargo
      Dell Technologies price target raised to $120 from $90 at Wells Fargo
      08:22 Today Northland
      VMware downgraded to Market Perform from Outperform at Northland
      08:03 Today Credit Suisse
      Dell Technologies price target raised to $95 from $80 at Credit Suisse
      KSU Kansas City Southern
      $262.01 /

      +1.15 (+0.44%)

      06:43 Today Wells Fargo
      Kansas City Southern downgraded to Equal Weight from Overweight at Wells Fargo
      06:01 Today Barclays
      Canadian Pacific upgraded to Overweight from Equal Weight at Barclays
      05:27 Today Wells Fargo
      Kansas City Southern downgraded to Equal Weight from Overweight at Wells Fargo
      04/06/21 Susquehanna
      Canadian Pacific-KSU deal should clear regulatory hurdles, says Susquehanna
      CAPL CrossAmerica
      $19.49 /

      +0.04 (+0.21%)

      06:50 Today Raymond James
      CrossAmerica downgraded to Market Perform at Raymond James on valuation
      05:26 Today Raymond James
      CrossAmerica downgraded to Market Perform from Outperform at Raymond James
      11/30/20 Wells Fargo
      CrossAmerica downgraded to Underweight from Equal Weight at Wells Fargo
      08/18/20 RBC Capital
      CrossAmerica price target raised to $17 from $15 at RBC Capital
      PXD Pioneer Natural
      $150.74 /

      -2.39 (-1.56%)

      08:25 Today Scotiabank
      Scotiabank downgrades Pioneer Natural to Sector Perform amid sector shake-up
      06:04 Today Scotiabank
      Pioneer Natural downgraded to Sector Perform from Outperform at Scotiabank
      04/08/21 Truist
      Diamondback Energy price target raised to $115 from $105 at Truist
      04/06/21
      Fly Intel: Top five analyst downgrades
      INTC Intel
      $64.14 /

      -0.08 (-0.12%)

      VMW VMware
      $154.50 /

      -0.99 (-0.64%)

      KSU Kansas City Southern
      $262.01 /

      +1.15 (+0.44%)

      PXD Pioneer Natural
      $150.74 /

      -2.39 (-1.56%)

      INTC Intel
      $64.14 /

      -0.08 (-0.12%)

      VMW VMware
      $154.50 /

      -0.99 (-0.64%)

      KSU Kansas City Southern
      $262.01 /

      +1.15 (+0.44%)

      PXD Pioneer Natural
      $150.74 /

      -2.39 (-1.56%)

      INTC Intel
      $64.14 /

      -0.08 (-0.12%)

      VMW VMware
      $154.50 /

      -0.99 (-0.64%)

      KSU Kansas City Southern
      $262.01 /

      +1.15 (+0.44%)

      PXD Pioneer Natural
      $150.74 /

      -2.39 (-1.56%)

      INTC Intel
      $64.14 /

      -0.08 (-0.12%)

      VMW VMware
      $154.50 /

      -0.99 (-0.64%)

      KSU Kansas City Southern
      $262.01 /

      +1.15 (+0.44%)

      PXD Pioneer Natural
      $150.74 /

      -2.39 (-1.56%)

      Upgrade
      Fly Intel: Top five analyst upgrades » 09:53
      04/15/21
      04/15
      09:53
      04/15/21
      09:53
      BUD

      AB InBev

      $67.44 /

      +2.31 (+3.55%)

      , GSHD

      Goosehead Insurance

      $104.65 /

      +0.9 (+0.87%)

      , HSY

      Hershey

      $160.04 /

      +1.88 (+1.19%)

      , CP

      Canadian Pacific

      $377.00 /

      +2.8 (+0.75%)

      , UPS

      UPS

      $178.37 /

      +2.32 (+1.32%)

      Catch up on today's…

      Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. AB InBev (BUD) upgraded to Overweight from Equal Weight at Barclays with analyst Laurence Whyatt saying market expectations of the company's margins declining in FY21 is "too pessimistic." 2. Goosehead (GSHD) upgraded to Outperform from Market Perform at Keefe Bruyette with analyst Meyer Shields citing the recent share weakness and the company's strong near-term premium growth prospects. 3. Hershey (HSY) upgraded to Buy from Neutral at Goldman Sachs with analyst Jason English believing 2020 was the beginning of a three-plus year cycle of "outsized growth" for Hershey as the confection industry "leverages its unique pricing power" to expand revenue and profits at a time when input costs are "non-daunting." 4. Canadian Pacific (CP) upgraded to Overweight from Equal Weight at Barclays with analyst Brandon Oglenski favoring non-rail exposure "within a transport sector likely to witness accelerating fundamentals beyond 2021." 5. UPS (UPS) upgraded to Equal Weight from Underweight at Barclays with analyst Brandon Oglenski citing momentum in parcel markets for the upgrade as well as the stock's relative valuation and $5.5B liability bailout. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

      ShowHide Related Items >><<
      BUD AB InBev
      $67.44 /

      +2.31 (+3.55%)

      GSHD Goosehead Insurance
      $104.65 /

      +0.9 (+0.87%)

      HSY Hershey
      $160.04 /

      +1.88 (+1.19%)

      CP Canadian Pacific
      $377.00 /

      +2.8 (+0.75%)

      UPS UPS
      $178.37 /

      +2.32 (+1.32%)

      BUD AB InBev
      $67.44 /

      +2.31 (+3.55%)

      04:50 Today Barclays
      AB InBev upgraded to Overweight from Equal Weight at Barclays
      04/06/21 Deutsche Bank
      AB InBev named 'Catalyst Call - Sell Idea' at Deutsche Bank
      03/01/21 Morgan Stanley
      AB InBev price target lowered to EUR 56 from EUR 61 at Morgan Stanley
      02/26/21 Barclays
      AB InBev price target raised to EUR 59 from EUR 54 at Barclays
      GSHD Goosehead Insurance
      $104.65 /

      +0.9 (+0.87%)

      04:46 Today Keefe Bruyette
      Goosehead upgraded to Outperform from Market Perform at Keefe Bruyette
      02/02/21 RBC Capital
      Goosehead Insurance price target raised to $155 from $120 at RBC Capital
      11/17/20 BofA
      Goosehead Insurance reinitiated with a Neutral at BofA
      10/30/20 RBC Capital
      Goosehead Insurance price target raised to $120 from $90 at RBC Capital
      HSY Hershey
      $160.04 /

      +1.88 (+1.19%)

      04:59 Today Goldman Sachs
      Hershey upgraded to Buy from Neutral at Goldman Sachs
      03/17/21
      Fly Intel: Top five analyst upgrades
      03/17/21 Piper Sandler
      Hershey upgraded to Overweight on cost visibility at Piper Sandler
      03/16/21 Piper Sandler
      Hershey upgraded to Overweight from Neutral at Piper Sandler
      CP Canadian Pacific
      $377.00 /

      +2.8 (+0.75%)

      06:01 Today Barclays
      Canadian Pacific upgraded to Overweight from Equal Weight at Barclays
      04/09/21 Scotiabank
      Canadian Pacific price target raised to C$516 from C$510 at Scotiabank
      04/06/21 Susquehanna
      Canadian Pacific-KSU deal should clear regulatory hurdles, says Susquehanna
      03/31/21 National Bank
      National Bank upgrades Canadian Pacific on likelihood of deal approval
      UPS UPS
      $178.37 /

      +2.32 (+1.32%)

      06:24 Today Citi
      Citi opens '90-day positive catalyst watch' on UPS, boosts target
      06:06 Today Barclays
      UPS upgraded to Equal Weight from Underweight at Barclays
      06:00 Today Barclays
      UPS upgraded to Equal Weight from Underweight at Barclays
      03/26/21 Vertical Research
      UPS initiated with a Buy at Vertical Research
      BUD AB InBev
      $67.44 /

      +2.31 (+3.55%)

      GSHD Goosehead Insurance
      $104.65 /

      +0.9 (+0.87%)

      HSY Hershey
      $160.04 /

      +1.88 (+1.19%)

      CP Canadian Pacific
      $377.00 /

      +2.8 (+0.75%)

      UPS UPS
      $178.37 /

      +2.32 (+1.32%)

      BUD AB InBev
      $67.44 /

      +2.31 (+3.55%)

      HSY Hershey
      $160.04 /

      +1.88 (+1.19%)

      UPS UPS
      $178.37 /

      +2.32 (+1.32%)

      BUD AB InBev
      $67.44 /

      +2.31 (+3.55%)

      HSY Hershey
      $160.04 /

      +1.88 (+1.19%)

      CP Canadian Pacific
      $377.00 /

      +2.8 (+0.75%)

      UPS UPS
      $178.37 /

      +2.32 (+1.32%)

      BUD AB InBev
      $67.44 /

      +2.31 (+3.55%)

      UPS UPS
      $178.37 /

      +2.32 (+1.32%)

      Conference/Events
      House Financial Services Committee to hold a virtual hearing » 09:52
      04/15/21
      04/15
      09:52
      04/15/21
      09:52

      The Subcommittee on…

      Story temporarily locked.
      To read stories as they happen please subscribe, Login above, or return tomorrow

      Get Free Trial

      Recommendations
      Wells Fargo price target raised to $47 from $37 at Argus » 09:51
      04/15/21
      04/15
      09:51
      04/15/21
      09:51
      WFC

      Wells Fargo

      $41.48 /

      -0.53 (-1.26%)

      Argus analyst Stephen…

      Story temporarily locked.
      To read stories as they happen please subscribe, Login above, or return in 9 minutes

      Get Free Trial

      ShowHide Related Items >><<
      WFC Wells Fargo
      $41.48 /

      -0.53 (-1.26%)

      WFC Wells Fargo
      $41.48 /

      -0.53 (-1.26%)

      09:19 Today Evercore ISI
      Wells Fargo price target raised to $48 from $38 at Evercore ISI
      07:42 Today Raymond James
      Wells Fargo price target raised to $50 from $42 at Raymond James
      07:09 Today BMO Capital
      Wells Fargo price target raised to $43 from $40 at BMO Capital
      07:00 Today Barclays
      Wells Fargo price target raised to $46 from $42 at Barclays
      WFC Wells Fargo
      $41.48 /

      -0.53 (-1.26%)

      WFC Wells Fargo
      $41.48 /

      -0.53 (-1.26%)

      WFC Wells Fargo
      $41.48 /

      -0.53 (-1.26%)

      WFC Wells Fargo
      $41.48 /

      -0.53 (-1.26%)

      Get Full Fly Access

      Breaking market intelligence sent straight to you
      Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
      Up-to-date information on important industry events
      Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
      News focused on the companies in your portfolio
      Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.